Q1 SCIENTIFIC
ActiveFinancials · financial year 2025, abbreviated format
Annual accounts 2025 filed on 16-06-2026 at the NBB all 3 filings
2023 to 2025, 3 financial years
The operating result for 2025 is a loss of €750,577, larger than the loss of €515,219 in 2024.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Average staff per financial year, in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Scientific research and development (NACE 72). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).
Staff
| Item | 31-12-2023 | 31-12-2024 | 31-12-2025 |
|---|---|---|---|
| Employees at the balance-sheet date | 2 | 2 | 4 |
| full-time | 2 | 2 | 4 |
| part-time | 0 | 0 | 0 |
| in full-time equivalents | 2 | 2 | 4 |
| Average over the year, in full-time equivalents | 1.4 | 2.9 | 3.5 |
| On a permanent contract | 2 | 2 | 4 |
| Joined | 2 | 2 | 3 |
| Left | 0 | 2 | 1 |
Source: social balance sheet in the 2023 to 2025 annual accounts
Investments
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Tangible fixed assets | €989,103 | €205,708 | €291,724 |
| Intangible fixed assets | €25,088 | - | - |
| Financial fixed assets | €20,000 | - | €3,000 |
| Depreciation and write-downs of the year | €46,101 | €87,686 | €122,810 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Comparable companies
These companies have the same main activity as Q1 SCIENTIFIC: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €1.2m and €4.3m, founded between 2020 and 2022.
| Company | Founded | Total assets | Equity | Gross margin | Net result | FTE | Financial year |
|---|---|---|---|---|---|---|---|
| Q1 SCIENTIFIC Villers-le-Bouillet | 2022 | €1.4m | -€2.8m | -€0.3m | -€1.0m | 3.5 | 2025 |
| BIO INX Gent | 2022 | €1.2m | -€0.3m | -€0.01m | -€0.3m | 4 | 2025 |
| BiometrIQ Kortrijk | 2020 | €1.6m | €1.1m | -€0.07m | -€0.6m | 4.1 | 2025 |
| LIVEDROP Liège | 2022 | €4.3m | €2.4m | -€0.006m | -€0.7m | 6.8 | 2025 |
| THERAtRAME Liège | 2022 | €2.7m | €1.8m | -€0.9m | -€2.1m | 10.1 | 2025 |
| STAM AGRO Dendermonde | 2020 | €1.9m | €0.9m | -€0.6m | -€1.1m | 1.4 | 2026 |
| ExeVir Bio Gent | 2020 | €3.8m | €3.7m | -€1.2m | -€1.9m | 1.8 | 2025 |
They were chosen from the 498 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Companies with the same profile, two years later
Historical observationIn July 2024, 7,639 companies had the same profile as Q1 SCIENTIFIC has now. Two years later, 8.8% had gone bankrupt and 84.9% were still going.
- Micro
- 2 to 5 years old
- negative equity
- a loss of 10% of the balance sheet or more
Another 0.7% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Q1 SCIENTIFIC itself is lower: 1.4% within 12 months. It rests on far more data about Q1 SCIENTIFIC than the profile alone.
Test of the method
The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,639 companies, not a prediction for Q1 SCIENTIFIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Remuneration, social security and pensions62 | €0.1m | €0.3m | €0.3m | ▲ 20.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.05m | €0.09m | €0.1m | ▲ 40.1% |
| Other operating charges640/8 | - | - | €0.01m | - |
| Gross operating margin9900 | -€0.8m | -€0.2m | -€0.3m | ▼ 79.1% |
| Operating profit (loss)9901 | -€1.0m | -€0.5m | -€0.8m | ▼ 45.7% |
| Financial charges65/66B | €0.1m | €0.2m | €0.2m | ▲ 7.1% |
| Recurring financial charges65 | €0.1m | €0.2m | €0.2m | ▲ 7.1% |
| Profit (loss) for the period before taxes9903 | -€1.1m | -€0.7m | -€1.0m | ▼ 34.9% |
| Profit (loss) for the period9904 | -€1.1m | -€0.7m | -€1.0m | ▼ 34.9% |
| Profit (loss) for the period to be appropriated9905 | -€1.1m | -€0.7m | -€1.0m | ▼ 34.9% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €1.3m | €1.4m | €1.4m | ▼ 1.1% |
| Fixed assets21/28 | €1.0m | €1.1m | €1.1m | ▲ 2.6% |
| Intangible fixed assets21 | €0.02m | €0.02m | €0.01m | ▼ 28.6% |
| Tangible fixed assets22/27 | €0.9m | €1.1m | €1.1m | ▲ 4.7% |
| Plant, machinery and equipment23 | €0.6m | €0.7m | €0.9m | ▲ 34.1% |
| Furniture and vehicles24 | €0.04m | €0.04m | €0.03m | ▼ 28.2% |
| Other tangible fixed assets26 | €0.3m | €0.3m | €0.2m | ▼ 14.8% |
| Assets under construction and advance payments27 | - | €0.1m | €0 | ▼ 100% |
| Financial fixed assets28 | €0.02m | €0.02m | €0.003m | ▼ 85.0% |
| Current assets29/58 | €0.3m | €0.3m | €0.3m | ▼ 14.1% |
| Amounts receivable within one year40/41 | €0.07m | €0.1m | €0.1m | ▼ 4.8% |
| Trade receivables40 | €0.03m | €0.1m | €0.1m | ▼ 26.4% |
| Other amounts receivable41 | €0.04m | €420 | €0.03m | ▲ 69× |
| Cash at bank and in hand54/58 | €0.2m | €0.1m | €0.1m | ▼ 23.9% |
| Deferred charges and accrued income490/1 | €0.03m | €0.04m | €0.04m | ▼ 9.5% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €1.3m | €1.4m | €1.4m | ▼ 1.1% |
| Equity10/15 | -€1.1m | -€1.8m | -€2.8m | ▼ 53.5% |
| Contributions10/11 | €0.06m | €0.06m | €0.06m | = |
| Profit (loss) carried forward14 | -€1.1m | -€1.9m | -€2.8m | ▼ 51.8% |
| Amounts payable17/49 | €2.4m | €3.2m | €4.2m | ▲ 29.4% |
| Amounts payable after more than one year17 | €2.2m | €3.1m | €4.0m | ▲ 31.3% |
| Financial debts170/4 | €2.2m | €3.1m | €4.0m | ▲ 31.3% |
| Amounts payable within one year42/48 | €0.1m | €0.1m | €0.1m | ▲ 5.3% |
| Trade debts44 | €0.08m | €0.08m | €0.08m | ▼ 1.1% |
| Suppliers440/4 | €0.08m | €0.08m | €0.08m | ▼ 1.1% |
| Taxes, remuneration and social security45 | €0.05m | €0.05m | €0.06m | ▲ 19.1% |
| Taxes450/3 | - | €0.001m | €0 | ▼ 100% |
| Remuneration and social security454/9 | €0.05m | €0.05m | €0.06m | ▲ 21.9% |
| Other amounts payable47/48 | €0.005m | €0.006m | €0.005m | ▼ 15.2% |
| Accrued charges and deferred income492/3 | - | €0.02m | €0 | ▼ 100% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | -€1.1m | -€0.7m | -€1.0m | ▼ 34.9% |
| + Depreciation and write-downs630 | €0.05m | €0.09m | €0.1m | ▲ 40.1% |
| Operating cash flow (approximation) | -€1.1m | -€0.6m | -€0.8m | ▼ 34.1% |
| Investment in fixed assets (approximation) | - | -€0.2m | -€0.2m | ▲ 26.4% |
| Change in cash | - | -€0.04m | -€0.03m | ▲ 4.4% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.